Results 201 to 210 of about 914,658 (345)

Translation of the clinical pharmacology findings into clinical practise; An example from the world of diabetes during the last two decades

, 2018
Päivi M. Paldánius
openalex   +2 more sources

Clinical Pharmacology and Therapeutics . Official publication of the American Therapeutic Society. Vol. 1. No. 1. January-February, 1960. WALTER MODELL, M.D., Editor, 1300 York Avenue, New York 21, N. Y. Published bimonthly. Subscription rates [PDF]

, 1960
H. M. LIVINGSTONE
openalex   +1 more source

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt, Marius Ygonia, Ali Manouchehrinia, Philippe Lefrançois, Ingrid Kockum, Adil Harroud   +5 more
wiley   +1 more source

Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS-CoV-2 Variants. [PDF]

Clin Transl Sci
Wang Q, Nader A, Peppercorn A, Skingsley A, Lloyd E, Stella AO, Walker J, Garner C.   +7 more
europepmc   +1 more source

Pharmacological Mechanism and Clinical Research Progress of Cordyceps Sinensis Preparations (Bailing Capsules) in the Treatment of Chronic Kidney Disease

Linhui Yang, Tao Yin, Yuehong Li
openalex   +1 more source

Effects of Biological Sex and Age on Cerebrospinal Fluid Markers—A Retrospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cerebrospinal fluid (CSF) analysis is a key diagnostic tool for neurological diseases. To date, only a few studies have investigated in larger cohorts the effect of age and biological sex on diagnostic markers extracted from CSF. Methods For this retrospective observational study, 4163 CSF findings (2012–2020) were evaluated.
Isabel‐Sophie Hafer, Simon Faissner, Ralf Gold, Aiden Haghikia   +3 more
wiley   +1 more source

Evaluation of the Accuracy and Reliability of Responses Generated by Artificial Intelligence Related to Clinical Pharmacology. [PDF]

J Clin Med
Ordak M, Adamczyk J, Oskroba A, Majewski M, Nasierowski T.   +4 more
europepmc   +1 more source

Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay

, 1998
Jean-Yves le Cotonnec, HervéClaude Porchet, Vanya Beltrami, Alain Munafo   +3 more
openalex   +1 more source

Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Adrenoleukodystrophy is a rare inherited peroxisomal disease caused by pathogenic variants in the ABCD1 gene located on the X chromosome. Although the most severe central nervous system and adrenal complications typically affect only men with adrenoleukodystrophy, the majority of women develop myeloneuropathy symptoms in adulthood.
Chenwei Yan, Elizabeth I. Pierpont, Amena S. Fine, Reena V. Kartha   +3 more
wiley   +1 more source

Clinical Pharmacology Profile of the Claudin 18.2 Antibody Zolbetuximab. [PDF]

Clin Pharmacokinet
Yang J, Yamada A, Shitara K, Xu RH, Ilson D, Lonardi S, Klempner SJ, Ueno Y, Takeuchi M, Pavese J, Wojtkowski T, Matsangou M, Poondru S.   +12 more
europepmc   +1 more source